{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:43:21Z","timestamp":1792637001929,"version":"4.5.0"},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec id=\"ab-doi260036-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Basal cell carcinoma (BCC) is the most common type of skin cancer worldwide. Particularly on the face, its locally destructive growth leads to functional and aesthetic impairment. Early diagnosis enables less invasive treatment. Line-field confocal optical coherence tomography (LC-OCT) is an effective noninvasive imaging method for the diagnosis of BCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi260036-5\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate whether LC-OCT paired with artificial intelligence (AI)\u2013assisted image recognition can identify subclinical BCCs through systematic screening of inconspicuous facial skin in patients at high risk of developing BCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi260036-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective cross-sectional feasibility study was conducted from April 2025 to October 2025 at the Department of Dermatology, Uniklinikum Erlangen, in Erlangen, Germany. Consecutive patients receiving inpatient care who had at least 2 established BCC risk factors were enrolled in the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi260036-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>After the exclusion of lesions macroscopically suggestive of BCC, inconspicuous facial skin was systematically examined using AI-assisted LC-OCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi260036-8\">\n                    <jats:title>Main Outcome and Measure<\/jats:title>\n                    <jats:p>The prespecified main outcome was positive predictive value (PPV) of AI-assisted LC-OCT for histologically confirmed subclinical BCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi260036-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 150 patients (mean [SD] age, 72.9 [10.3] years; 57 [38.0%] female; 93 [62.0%] male), 17 subclinical BCCs were identified in 14 patients (9.3%). Of 18 lesions diagnosed as BCC with AI-assisted LC-OCT, 15 were histologically confirmed, corresponding to a PPV of 83.3% (95% CI, 58.6%-96.4%). One lesion had a false-positive result (actinic keratosis); 2 patients declined biopsy. In a sensitivity analysis including the 2 nonbiopsied lesions that were confirmed with expert analysis, PPV was 94.4% (95% CI, 72.7%-99.9%). The distribution of BCC subtypes included 13 cases of superficial BCCs (76.5%), followed by 3 cases of nodular BCCs (17.6%), and 1 case of infiltrative BCC (5.9%). Subtype classification was accurate in 13 of 15 histologically confirmed cases (86.7% [95% CI, 59.5%-98.3%]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi260036-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cross-sectional feasibility study, the findings suggest that systematic screening with AI-assisted LC-OCT may be a feasible approach for BCC detection at a preclinical stage in populations at high risk for BCC. Further prospective studies are needed to assess the sensitivity and cost-effectiveness of this method, and whether early detection translates to tangible clinical benefit before implementation in routine care can be recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamadermatol.2026.2992","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:30:35Z","timestamp":1787153435000},"page":"1018","source":"Crossref","is-referenced-by-count":2,"title":["AI-Assisted Line-Field Confocal Optical Coherence Tomography to Detect Subclinical Basal Cell Carcinoma"],"prefix":"10.1001","volume":"162","author":[{"given":"Moritz","family":"Ronicke","sequence":"first","affiliation":[{"name":"Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"CCC Erlangen-EMN, CCC WERA, Bavarian Center for Cancer Research (Bayerisches Zentrum f\u00fcr Krebsforschung, BZKF), Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"D\u00fcrr","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"CCC Erlangen-EMN, CCC WERA, Bavarian Center for Cancer Research (Bayerisches Zentrum f\u00fcr Krebsforschung, BZKF), Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"H\u00f6ner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"CCC Erlangen-EMN, CCC WERA, Bavarian Center for Cancer Research (Bayerisches Zentrum f\u00fcr Krebsforschung, BZKF), Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9onie","family":"Staats","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"CCC Erlangen-EMN, CCC WERA, Bavarian Center for Cancer Research (Bayerisches Zentrum f\u00fcr Krebsforschung, BZKF), Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Erdmann","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"CCC Erlangen-EMN, CCC WERA, Bavarian Center for Cancer Research (Bayerisches Zentrum f\u00fcr Krebsforschung, BZKF), Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Berking","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"CCC Erlangen-EMN, CCC WERA, Bavarian Center for Cancer Research (Bayerisches Zentrum f\u00fcr Krebsforschung, BZKF), Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"doi260036r1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer.","volume":"166","author":"Lomas","year":"2012","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi260036r2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/JOM.0000000000001217","article-title":"Occupational UV-exposure is a major risk factor for basal cell carcinoma: results of the population-based case-control study FB-181.","volume":"60","author":"Schmitt","year":"2018","journal-title":"J Occup Environ Med"},{"issue":"24","key":"doi260036r3","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1093\/jnci\/88.24.1848","article-title":"Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy.","volume":"88","author":"Karagas","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"doi260036r4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S1470-2045(22)00347-3","article-title":"Optical coherence tomography versus punch biopsy for diagnosis of basal cell carcinoma: a multicentre, randomised, non-inferiority trial.","volume":"23","author":"Adan","year":"2022","journal-title":"Lancet Oncol"},{"issue":"8","key":"doi260036r5","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/jdv.20459","article-title":"Line-field confocal optical coherence tomography of basal cell carcinoma: a retrospective study on diagnostic performance.","volume":"39","author":"Mtimet","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"doi260036r6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/jdv.17078","article-title":"Line-field confocal optical coherence tomography of basal cell carcinoma: a descriptive study.","volume":"35","author":"Suppa","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"doi260036r7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/jdv.15884","article-title":"Key characteristics of basal cell carcinoma with large subclinical extension.","volume":"34","author":"Greywal","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"doi260036r8","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/jdv.70099","article-title":"AI-assisted basal cell carcinoma diagnosis with LC-OCT: a multicentric retrospective study.","volume":"40","author":"Fischman","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"13","key":"doi260036r9","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.3390\/jcm13133830","article-title":"One-stop shop: diagnosis and treatment of basal cell carcinoma in one step.","volume":"13","author":"F\u00fcnfer","year":"2024","journal-title":"J Clin Med"},{"issue":"5","key":"doi260036r10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/jdv.14650","article-title":"Reflectance confocal microscopy identification of subclinical basal cell carcinomas during and after vismodegib treatment.","volume":"32","author":"Couzan","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"doi260036r11","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s10103-016-2043-3","article-title":"The invisible basal cell carcinoma: how reflectance confocal microscopy improves the diagnostic accuracy of clinically unclear facial macules and papules.","volume":"31","author":"Ruini","year":"2016","journal-title":"Lasers Med Sci"},{"issue":"3","key":"doi260036r12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/jdv.14611","article-title":"Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%\/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a phase III, randomized, double-blind, vehicle-controlled trial.","volume":"32","author":"Ulrich","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"doi260036r13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1046\/j.1365-2133.2002.04804.x","article-title":"Variations of basal cell carcinomas according to gender, age, location and histopathological subtype.","volume":"147","author":"Scrivener","year":"2002","journal-title":"Br J Dermatol"},{"issue":"10","key":"doi260036r14","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.ejca.2013.03.010","article-title":"Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis.","volume":"49","author":"Flohil","year":"2013","journal-title":"Eur J Cancer"},{"issue":"11","key":"doi260036r15","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1038\/jid.2015.244","article-title":"Predicting the risk of a second basal cell carcinoma.","volume":"135","author":"Verkouteren","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"6","key":"doi260036r16","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1364\/BOE.525524","article-title":"Large area robotically assisted optical coherence tomography (LARA-OCT).","volume":"15","author":"Lotz","year":"2024","journal-title":"Biomed Opt Express"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2853052\/jamadermatology_ronicke_2026_oi_260036_1792511068.57586.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:00:46Z","timestamp":1792594846000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2853052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2026.2992","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}